Nu-Med Plus (NUMD) Net Equity Issued and Repurchased (2012 - 2021)
Nu-Med Plus' (NUMD) quarterly Net Equity Issued and Repurchased came in at $30000.0 in Q1 2021, down 85.0% quarter-over-quarter from $200000.0 in Q4 2020.
Powered by 
Analysis
Nu-Med Plus (NUMD) Net Equity Issued and Repurchased (2012 - 2021) Analysis & Trends
Nu-Med Plus has disclosed Net Equity Issued and Repurchased across 9 years of filings, most recently posting $30000.0 for Q1 2021.
- In Q1 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $30000.0; the TTM figure through Dec 2021 stood at $30000.0 (down 89.47% YoY), while the FY2021 annual figure was $30000.0, down 85.0% from the prior year.
- Net Equity Issued and Repurchased came in at $30000.0 for Q1 2021 at Nu-Med Plus, down from $200000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $665700.0 in Q3 2017 to a low of -$729705.0 in Q4 2017.
- Average Net Equity Issued and Repurchased over 4 years is $120270.0, with a median of $97500.0 recorded in 2018.
- The largest YoY upside for Net Equity Issued and Repurchased was 26528.0% in 2017 against a maximum downside of 29099.88% in 2017.
- Over 4 years, Net Equity Issued and Repurchased stood at -$729705.0 in 2017, then surged by 111.65% to $85000.0 in 2018, then surged by 135.29% to $200000.0 in 2020, then slumped by 85.0% to $30000.0 in 2021.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $30000.0 in Q1 2021, $200000.0 in Q4 2020, and $85000.0 in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2018 | 85,000.00 |
| Sep 30, 2018 | 110,000.00 |
| Jun 30, 2018 | -8,220.00 |
| Mar 31, 2018 | 8,220.00 |
| Dec 31, 2017 | -729,705.00 |
| Sep 30, 2017 | 665,700.00 |
| Jun 30, 2017 | 435,205.00 |
| Mar 31, 2017 | 406,500.00 |
| Dec 31, 2016 | -2,499.00 |
| Sep 30, 2016 | 2,500.00 |
| Mar 31, 2016 | 107,000.00 |
| Dec 31, 2015 | 23,210.00 |
| Sep 30, 2015 | 28,800.00 |
| Jun 30, 2015 | 50,529.00 |
| Sep 30, 2014 | 90,001.00 |
| Jun 30, 2014 | 73,999.00 |
| Mar 31, 2014 | 38,400.00 |
| Dec 31, 2013 | 40,300.00 |